hrp0092p1-82 | GH and IGFs | ESPE2019
Assefi Aria Reza
, Chareca Cinthia
, Roca Fernanda
, Rubstein Adrian
, Ayala Luciana Celis
, Von Schulz Hausmann Cristian
Background: One of the main concerns in patients with growth disorders is to achieve optimal adherence to growth hormone (GH) treatment. For this it is important to identify patients with low adherence to treatment and to evaluate actions to improve it.The Merck Patient Support Program (PSP) carried out educational actions aimed at patients with low adherence and their parents, to raise their awareness of the importance of good adherence...